AQEC - ETF AI Analysis
Top Page
AQE Core ETF (AQEC)
Rating:69Neutral
Price Target:―
Positive Factors
Resilient Blue-Chip Holdings
Several top positions in well-known companies like Johnson & Johnson, Apple, Coca-Cola, and Novartis have shown strong or steady performance, helping support the fund despite recent market weakness.
Broad Sector Diversification
The ETF spreads its investments across multiple sectors such as health care, consumer defensive, financials, technology, and industrials, which can help reduce the impact if any one industry struggles.
Meaningful Fund Size
With several hundred million dollars in assets, the ETF is large enough to offer stability and tradability for everyday investors.
Negative Factors
Recent Weak Overall Performance
The fund has delivered negative returns so far this year and over the past month, which may concern investors looking for near-term strength.
High U.S. Market Concentration
Almost all of the ETF’s holdings are in U.S. companies, offering limited geographic diversification if the U.S. market underperforms.
Moderate Expense Ratio
The fund’s expense ratio is not especially low, meaning fees could take a noticeable bite out of long-term returns compared with cheaper index ETFs.
AQEC vs. SPDR S&P 500 ETF (SPY)
AUM595.50M
RegionGlobal
Expense Ratio0.49%
Beta0.72
IssuerArlington
Inception DateNov 18, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume23,180
30 Day Avg. Volume46,768
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
28.62Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering65
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AQEC Summary
AQE Core ETF (AQEC) is an actively managed fund that invests mainly in large, well-established companies, with a broad mix of sectors like health care, consumer goods, finance, and technology. It doesn’t track a fixed index, but instead aims to build a core, diversified portfolio of big global businesses, mostly based in the U.S. Well-known holdings include Johnson & Johnson, Berkshire Hathaway, Apple, and Coca-Cola. Someone might invest for broad, long-term growth and diversification in one fund. A key risk is that its stock prices can go up and down with the overall market.
How much will it cost me?The AQE Core ETF (AQEC) has an expense ratio of 0.49%, which means you’ll pay $4.90 per year for every $1,000 invested. This is higher than average because it is actively managed, requiring more resources to select and manage investments compared to passively managed funds that track an index.
What would affect this ETF?The AQE Core ETF (AQEC) could benefit from global economic growth, particularly in sectors like Technology and Health Care, which are well-represented in its portfolio. However, it may face challenges from rising interest rates, which could impact large-cap companies, and geopolitical tensions that might disrupt global markets. Its broad geographic exposure and focus on established companies provide diversification, but sector-specific risks, such as regulatory changes in Technology or Health Care, could also affect performance.
AQEC Top 10 Holdings
AQEC leans heavily into global health care and consumer staples, with names like Johnson & Johnson, Novartis, GSK, and Coca-Cola quietly powering the fund thanks to steady-to-rising recent performance. Apple has been a bright spot over the past few months, though it’s lost a bit of steam lately, while Berkshire Hathaway and General Dynamics add a more defensive, industrial-financial backbone. The main drag comes from Microsoft and Ryan Specialty Group, both lagging this year. Overall, it’s a globally diversified, large-cap mix with no single stock dominating the story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 2.12% | $12.71M | $633.19B | 71.54% | 78 Outperform | |
| Berkshire Hathaway B | 1.99% | $11.94M | $1.10T | 6.10% | 66 Neutral | |
| General Dynamics | 1.97% | $11.79M | $101.02B | 26.29% | 80 Outperform | |
| RTX | 1.95% | $11.68M | $268.33B | 38.96% | 74 Outperform | |
| Apple | 1.93% | $11.54M | $4.53T | 47.93% | 79 Outperform | |
| GlaxoSmithKline | 1.91% | $11.47M | $108.14B | 38.56% | 77 Outperform | |
| Ryan Specialty Group | 1.81% | $10.83M | $11.08B | -36.99% | 60 Neutral | |
| Roche Holding | 1.78% | $10.67M | $337.33B | 27.95% | 74 Outperform | |
| Novartis | 1.78% | $10.63M | $290.07B | 29.05% | 80 Outperform | |
| Coca-Cola | 1.76% | $10.55M | $362.01B | 19.66% | 75 Outperform |
AQEC Technical Analysis
Positive
―
Price Trends
24.09
Positive
24.21
Positive
Market Momentum
0.17
Negative
58.55
Neutral
82.28
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AQEC, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 24.05, equal to the 50-day MA of 24.09, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.17 indicates Negative momentum. The RSI at 58.55 is Neutral, neither overbought nor oversold. The STOCH value of 82.28 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AQEC.
AQEC Peer Comparison
Comparison Results
Performance Comparison
AQEC
AQE Core ETF
24.64
-0.10
-0.40%
FHEQ
Fidelity Hedged Equity ETF
―
―
―
FFLG
Fidelity Fundamental Large Cap Growth ETF
―
―
―
BBHL
BBH Select Large Cap ETF
―
―
―
TEQI
T. Rowe Price Equity Income ETF
―
―
―
FYEE
Fidelity Yield Enhanced Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents